Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fort Wayne Medical Oncology and Hematology (FWMOH) is a premier provider of comprehensive cancer care and blood disorder treatments serving Northeast Indiana and the surrounding tri-state area. The practice offers a full range of services including chemotherapy, immunotherapy, advanced diagnostic imaging, and an on-site specialty pharmacy. FWMOH is distinguished by its robust clinical research department, which provides patients access to national Phase 1, 2, and 3 clinical trials for various malignancies. In 2023, the practice joined the American Oncology Network (AON), a move that integrated its clinical expertise with a national platform to enhance patient outcomes and operational efficiency. The organization remains a critical hub for community-based oncology, combining personalized patient care with cutting-edge investigational therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fort Wayne Medical Oncology and Hematology.